CPRX

Catalyst Pharmaceuticals
CPRX

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$2.82B
EV
$2.31B
Shares Outstanding
128.95M
Beta
0.79

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$34.00
P/E 2025E
16.24x
P/Revenue 2025E
5.06x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Catalyst Pharmaceuticals, Inc.

gainify
CPRX

Catalyst Pharmaceuticals, Inc.

CPRX

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampri...

Sector

Healthcare

Industry

Biotechnology

CEO

Daly, Richard John

Employees

181

IPO Date

2006-11-08

Headquarters

355 Alhambra Circle, Suite 801, Coral Gables, Florida, 33134, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved